What is the main conclusion of Jason Lye's outside-written Eye on Patents column regarding China's chemistry patent activity?

Jason Lye's column concludes that China has risen to become the world’s most prolific filer of chemistry patents, though it is not yet a global leader in patent quality; however, it is quickly closing the gap with leaders like the US.

What is the purpose of C&EN's Eye on Patents column, and how has its authorship evolved since its launch?

The Eye on Patents column, launched by C&EN in May, explores trends in chemistry-related patenting using data from CAS; the first six installments were collaborations with CAS, and the first outside-written column—published yesterday—was authored by patent strategist Jason Lye, marking an expansion in the column’s authorship model.

Business Watch: Origin Materials to shut down; biotech IPOs boom

May 5, 2026

C&EN launches 'Eye on Patents' column with CAS data on China's chemistry IP growth, while Business Watch covers Origin Materials shutdown and biotech IPO boom.

cen

2026-05-05

Business Watch: Origin Materials to shut down; biotech IPOs boom

FAQ

Scan to get the App